Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: Preventive and therapeutic implications

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Epidemiologic studies strongly support that triple-negative breast cancers (TNBCs) may be distinct entities as compared with estrogen receptor (ER)+ tumors, suggesting that the etiologic factors, clinical characteristics, and therapeutic possibilities may vary by molecular subtypes. Many investigations propose that reproductive factors and exogenous hormone use differently or even quite inversely affect the risk of TNBCs and ER+ cancers. Controversies concerning the exact role of even the same risk factor in TNBC development justify that the biological mechanisms behind the initiation of both TNBCs and non-TNBCs are completely obscure. To arrive at a comprehensive understanding of the etiology of different breast cancer subtypes, we should also reconsider our traditional concepts and beliefs regarding cancer risk factors. Malignancies are multicausal, but the disturbance of proper estrogen signaling seems to be a crucial risk factor for the development of mammary cancers. The grade of defect in metabolic and hormonal equilibrium is directly associated with TNBC risk for women during their whole life. Inverse impact of menopausal status or parity on the development of ER+ and ER- breast cancers may not be possible; these controversial results derive from the misinterpretation of percentage-based statistical evaluations. Exogenous or parity-associated excessive estrogen supply is suppressive against breast cancer, though the lower the ER expression of tumors, the weaker the anticancer capacity. In women, the most important preventive strategy against breast cancers - included TNBCs - is the strict control and maintenance of hormonal equilibrium from early adolescence through the whole lifetime, particularly during the periods of great hormonal changes.

Original languageEnglish
Pages (from-to)147-164
Number of pages18
JournalOncoTargets and Therapy
Volume7
DOIs
Publication statusPublished - Jan 23 2014

Keywords

  • Cancer prevention
  • Infertility
  • Insulin resistance
  • Menopause
  • Metabolic syndrome
  • Type 2 diabetes

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: Preventive and therapeutic implications'. Together they form a unique fingerprint.

  • Cite this